Begin typing your search above and press return to search.
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
Debunking myth of Israel’s existence
access_time 23 Oct 2023 7:01 AM GMT
Homechevron_rightLifestylechevron_rightHealthchevron_rightCentre takes steps to...

Centre takes steps to develop vaccines for monkeypox disease

Centre takes steps to develop vaccines for monkeypox disease

New Delhi: In the wake of increasing monkeypox cases in the country, the Centre has set a national task force to monitor the development of diagnostics and vaccines, said the Union Health Minister Mansukh Madaviya in the Rajya Sabha.

Apart from taking various measures to curb the spread of the disease, he said efforts to develop testing kits and vaccines are on now.

The Union Health Minister informed this while replying to queries in Rajya Sabha during Question Hour.

Till date eight cases of the disease have been detected in India, out of which five have foreign travel history, the Minister of Health and Family Welfare said. The Indian Council of Medical Research (ICMR) has successfully isolated the monkeypox virus and an expression of interest has been floated for research institutions, vaccine and diagnostic kits manufacturers in India to take the virus strain for further research to develop a vaccine in the country, he added.

In a written reply to a question on measures and preventive action initiated by the government, the minister said, "A national task force on monkeypox disease has been constituted to monitor the development of diagnostics and vaccines for the management of monkeypox disease."

Airport and port health officers have been instructed to remain vigilant and undertake rigorous health screening of incoming international passengers.

The minister said the National Institute of Virology, Pune under ICMR has been designated as a referral laboratory for testing suspected cases. In addition, 15 other ICMR-VRDL (Viral Research and Diagnostic Laboratory) network laboratories have been optimised to undertake diagnostic testing for monkeypox, he explained.

He said central teams have been deployed, on the detection of confirmed cases, to the affected districts to assist in control and containment efforts by state authorities.

In response to another supplementary question, Mandaviya said the government has relied on the experience of tackling COVID-19, to be alert and prepared in advance to prevent the spread of any disease. He claimed that when the disease was first reported globally in May, India had already started preparing to tackle it.

While the first case in India was reported from Kerala on July 14, the minister said much before that on May 1, 2022, the Union government had given guidelines to all states, and not just for international airports, on surveillance mechanism and contact tracing, how to collect samples from suspected cases and sending it to recognised laboratories for testing.

With the disease spreading only through close contact, he said no specific community is at risk and the government has taken up steps to create awareness about common symptoms, reporting of suspected cases and prevention from the disease.

Mandaviya said WHO has reported 18,000 confirmed cases of monkeypox globally from 78 countries and five deaths till July 27, 2022.

PTI Input

Show Full Article
TAGS:vaccinesMonkeypoxviral diseaseMansukh Madaviya
Next Story